Rasha Abdelhady

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Molecular Docking

Cell Cycle Arrest

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed F Khalil, Tarek F El-Moselhy, Eman A El-Bastawissy, Rasha Abdelhady, Nancy S Younis, Mervat H El-Hamamsy
Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Ahmed F Khalil, Tarek F El-Moselhy, Eman A El-Bastawissy, Rasha Abdelhady, Nancy S Younis, Mervat H El-Hamamsy
Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Rana M Abdelnaby, Heba S Rateb, Omaima Ali, Ahmed S Saad, Rania I Nadeem, Sahar M Abou-Seri, Kamilia M Amin, Nancy S Younis, Rasha Abdelhady
Dual PI3K/Akt Inhibitors Bearing Coumarin-Thiazolidine Pharmacophores as Potential Apoptosis Inducers in MCF-7 Cells. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)